 Its make-or-break time for Neurocrine Biosciences essential tremors treatment, analysts say, as NBIX stock trends sideways. The post The Make-Or-Break Moment Is Here For Highly Rated Neurocrine Biosciences appeared first on Investors Business Daily. 